RESEARCH TRIANGLE PARK, NC – The Burroughs Wellcome Fund Board of Directors is pleased to announce the 2022 award recipients for the Next Gen Pregnancy Initiative.
The Next Gen Pregnancy initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach healthy and adverse pregnancy outcomes using creative basic and translation science methods. Each award provides up to $500,000 over a four-year period.
“The proposals selected this year are led by innovative scientists who are asking a variety of important questions about adverse pregnancy outcomes,” said Dr. Paige Cooper, BWF Program Officer. “They are incorporating cutting edge methods we believe have the potential to advance solutions in this area.”
The 2022 Next Gen Pregnancy Initiative recipients are:
Yalda Afshar MD, PhD
University of California-Los Angeles School of Medicine
Noninvasive Prenatal Diagnostics for Placenta Accreta Spectrum Disorders
David R Archer PhD
Emory University
Defining the Drivers of Poor Pregnancy Outcomes in Sickle Cell Disease
Jacqueline Ho, MD
Children’s Hospital of Pittsburgh
Prenatal programming of long-term kidney health by in utero exposure to maternal diabetes.
Lisa A. Joss-Moore, PhD
University of Utah
Uteroplacental Insufficiency Disrupts Placental-Fetal Lipid Regulation and Dynamics
Kellie A Jurado, PhD
University of Pennsylvania Perelman School of Medicine
Immunological functions of fetal red blood cells during pregnancy
Vincent J. Lynch, PhD
State University of New York-Buffalo
Evolution of human specific pregnancy traits
Monica Ailawadi Mainigi, MD
University of Pennsylvania
The Role of Estrogen Metabolites in Abnormal Placentation
Elze Rackaityte, PhD
University of California-San Francisco
Antibody Surveillance of Human Development for Preterm Birth Diagnostics and Prevention
Jian Shu, PhD
Massachusetts General Hospital
Prediction of Preterm Birth through Single-Cell Genomics and Machine Learning
Chandrasekhar Yallampalli, DVM, PhD
Baylor College of Medicine
Transcriptome and proteome profiling to evaluate role of placenta specific complement activation in preeclampsia and fetal growth restriction
###
Media contacts: news@bwfund.org
Comments are closed.